Could Data From Million Species Spark New Cures for Markets
A venture-backed biotech startup unveils a plan to collect genomic data from 100 million species to fuel AI drug disc...
Recovering from budget neglect requires a clear plan: rebuild essential budgets, tackle debt strategically, and track progress weekly.
28,655 articlesA venture-backed biotech startup unveils a plan to collect genomic data from 100 million species to fuel AI drug disc...
As AI chips grab headlines, investors wonder if will cerebras soar after its IPO. While history offers clues, the pat...
Elon Musk’s clash with OpenAI doubles as a bid to launch xAI, with Tesla financing and strategic partnerships setting...
NVIDIA led the AI hardware rally, but the backbone of today’s AI deployments sits in memory and storage. This piece e...
Choosing exposure to AI through tech ETFs doesn't have to be hard. This guide compares XLK and VGT, focusing on which...
A risk-off mood is weighing on major cryptos as ETF redemptions surge. This guide breaks down the forces at work and ...
A CFO selling a substantial stake can spark questions about a company’s short-term risk and long-term strategy. This ...
As physical toll climbs for seasoned tradespeople, more are weighing claiming Social Security early. Industry forecas...
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Investors sent Joby Aviation stock higher after the company topped expectations on its latest results. This article b...
A discreet fund quietly builds a Mattel stake, signaling conviction or a calculated thesis. This article breaks down ...
A tiny investment can become a huge winner when the business model scales with a durable moat. This guide breaks down...